IVI Presents Two Posters at AMCP Nexus 2019

IVI presented two posters at AMCP Nexus 2019, the healthcare conference at the intersection of value and care. In the poster “Understanding Value Through the Patient’s Eyes: Perspectives from Patients with Genetic Mutations in Non-Small Cell Lung Cancer Treatment” researchers show how they examine the perspectives and experiences of patients diagnosed with mNSCLC, and the [...]

2019-11-01T16:34:07-06:00November 1st, 2019|IVI News, Research|

PRESS RELEASE: How Structural Uncertainty Impacts Value Estimates

In a new Value Blueprints research brief, IVI explores the concept of “structural uncertainty,” an important source of uncertainty that is not generally measured or addressed in cost-effectiveness models. In this research brief, we use the IVI-RA model to demonstrate how different structural assumptions lead to varying cost-effectiveness estimates. As our findings make clear, it [...]

2019-10-11T11:43:24-06:00September 4th, 2019|IVI News, Press, Publications, Research|

PRESS RELEASE: IVI Illustrates “Insurance Value” Using IVI-RA Model in Latest Research Brief

In a new Value Blueprints research brief, IVI explores the novel concept of “Insurance Value.” New medical technologies not only benefit patients, but also healthy people at risk of future illness. The insurance value arising from the decreased physical risk from illness is a potentially important dimension to consider in value assessment, especially when decisions [...]

2019-10-11T11:43:53-06:00July 25th, 2019|IVI News, Press, Publications, Research|

PRESS RELEASE: IVI Launches New Research Brief Series “Value Blueprints”

IVI launches a new research brief series to present research findings and method insights from the OSVP. Let’s sparks a conversation into next-gen value assessment. Read the full press release here.

2019-10-11T11:44:18-06:00May 20th, 2019|IVI News, Press, Publications, Research|

New IVI Research Shows Challenges with ICER Budget Impact Forecasting

IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the consequences of not accounting for uncertainty in value assessment. Read the full article here.

2018-12-20T17:46:29-06:00December 20th, 2018|Publications, Research|

PRESS RELEASE: IVI’s Patient Research Reveals Importance of Quality of Life in Assessing Non-Small Cell Lung Cancer Therapy Sequence Value

Los Angeles, CA – November 15, 2018 – The Innovation and Value Initiative (IVI) – a nonprofit dedicated to advancing the science and improving the practice of value assessment in healthcare – today released qualitative research evaluating what factors most impact the value of treatment to metastatic non-small cell lung cancer patients. According to the [...]

2018-11-15T16:00:32-06:00November 15th, 2018|IVI News, Press, Research|

IVI Releases Non-Small Cell Lung Cancer Patient Qualitative Research

IVI has released the results to their non-small cell lung cancer patient qualitative research, which was used in the development of the structure of upcoming OSVP designed to evaluate lung cancer therapy sequences. According to the research, which was conducted in collaboration with LUNGevity, patients reported valuing treatments that would help increase overall or progression [...]

2018-11-15T16:01:39-06:00November 15th, 2018|IVI News, Research|

IVI Open-Source Value Project on Display at ISPOR Europe

IVI economists showcased the results of multiple research streams supporting open-source value modeling initiative at the leading European conference for health economics and outcomes research. Presentation topics included: Development of open-source software for conducting value assessments; Implementation of a new approach for using public feedback to guide ongoing, iterative improvement of open-source value models; and [...]

2018-11-16T17:02:52-06:00November 14th, 2018|IVI News, Research|

PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies

Priorities Emerged Which Will Shape Version 2.0 of IVI’s RA Model Los Angeles, CA – September 20, 2018 -- The Innovation and Value Initiative (IVI) today released public feedback and recommendations from its Technical Expert Panel (TEP), an objective third party comprised of five leaders in health economics, epidemiology, rheumatology, and patient communities, which the [...]

2018-09-20T09:03:25-06:00September 20th, 2018|IVI News, Press, Research|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model [...]

2018-05-03T16:32:26-06:00April 16th, 2018|IVI News, Research|